CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

/C O R R E C T I O N -- Privo Technologies/

Phase 2PRV111Neutral
AI Analysis

Summary

Privo Technologies issued a correction to a news release regarding a clinical update from its ongoing Phase 2 trial of PRV111, a non-surgical therapy in development for early-stage oral cancer. The article provides no substantive clinical data or trial results.

Clinical Trial Data

Phase

2

Importance:2/10
Sentiment:
0.00
phase_2oral_cancerclinical_updatecorrection
Related Companies

Read the original article

Published by PR Newswire Pharma on October 7, 2026 4:31 PM

Read Original